Relationships Between Exercise and Appetite in Women With Loss of Control Eating

April 24, 2026 updated by: Katherine J. Forney, Ohio University
This pilot study is a first step in looking at the relationship between exercise and appetite in women with loss of control eating.

Study Overview

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Athens, Ohio, United States, 45701
        • Ohio University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Engage in loss of control eating at least 12 times in the last three months
  • Clinically significant eating disorder-related impairment (CIA > 15)
  • Minimum VO2max of 50th percentile for age and sex assigned at birth
  • Be willing to eat study-provided foods
  • Likes chocolate (at least 6/10 on 10 point scale)

Exclusion Criteria:

  • BMI < 18.5 kgm/2
  • Medical conditions that affect appetite or weight (e.g., diabetes mellitus, thyroid disease)
  • Recent pregnancy or breastfeeding (prior 6 months)
  • Relevant food allergies (e.g., wheat, chocolate)
  • Specific phobia, blood-injection-injury type
  • Medical condition that precludes safe participation in exercise (e.g., stress fracture)
  • Medications that acutely affect appetite (e.g., GLP-1 agonists; psychiatric medications allowed)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Rest, Fed Exercise, Fasted Exercise

At Study Visit 2, participants will eat breakfast and rest (abstain from exercise).

At Study Visit 3, participants will eat breakfast and exercise. At Study Visit 4, participants will abstain from breakfast and will engage in exercise.

Participants will eat breakfast but abstain from exercise
Participants will eat breakfast and engage in 30 minutes of physical activity at 75% of their personal V02max.
Participants will engage in 30 minutes of physical activity at their personal 75% V02max after abstaining from breakfast.
Experimental: Rest, Fasted Exercise, Fed Exercise

At Study Visit 2, participants will eat breakfast and rest (abstain from exercise).

At Study Visit 3, participants will abstain from breakfast and will engage in exercise.

At Study Visit 4, participants will eat breakfast and exercise.

Participants will eat breakfast but abstain from exercise
Participants will eat breakfast and engage in 30 minutes of physical activity at 75% of their personal V02max.
Participants will engage in 30 minutes of physical activity at their personal 75% V02max after abstaining from breakfast.
Experimental: Fed Exercise, Rest, Fasted Exercise

At Study Visit 2, participants will eat breakfast and exercise. At Study Visit 3, participants will eat breakfast and rest (abstain from exercise).

At Study Visit 4, participants will abstain from breakfast and will engage in exercise.

Participants will eat breakfast but abstain from exercise
Participants will eat breakfast and engage in 30 minutes of physical activity at 75% of their personal V02max.
Participants will engage in 30 minutes of physical activity at their personal 75% V02max after abstaining from breakfast.
Experimental: Fed Exercise, Fasted Exercise, Rest

At Study Visit 2, participants will eat breakfast and exercise. At Study Visit 3, participants will abstain from breakfast and will engage in exercise.

At Study Visit 4, participants will eat breakfast and rest (abstain from exercise).

Participants will eat breakfast but abstain from exercise
Participants will eat breakfast and engage in 30 minutes of physical activity at 75% of their personal V02max.
Participants will engage in 30 minutes of physical activity at their personal 75% V02max after abstaining from breakfast.
Experimental: Fasted Exercise, Fed Exercise, Rest

At Study Visit 2, participants will abstain from breakfast and will engage in exercise.

At Study Visit 3, participants will eat breakfast and exercise. At Study Visit 4, participants will eat breakfast and rest (abstain from exercise)

Participants will eat breakfast but abstain from exercise
Participants will eat breakfast and engage in 30 minutes of physical activity at 75% of their personal V02max.
Participants will engage in 30 minutes of physical activity at their personal 75% V02max after abstaining from breakfast.
Experimental: Fasted Exercise, Rest, Fed Exercise

At Study Visit 2, participants will abstain from breakfast and will engage in exercise.

At Study Visit 3, participants will eat breakfast and rest (abstain from exercise).

At Study Visit 4, participants will eat breakfast and exercise.

Participants will eat breakfast but abstain from exercise
Participants will eat breakfast and engage in 30 minutes of physical activity at 75% of their personal V02max.
Participants will engage in 30 minutes of physical activity at their personal 75% V02max after abstaining from breakfast.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Relative Energy Intake
Time Frame: Food intake from 8 am to 8 am; Energy expenditure from approximately 9 am to 9:05 am and 9:25 to 9:30 am, coinciding with study condition (rest or exercise)
Relative energy intake for 24 hours will be calculated as absolute energy intake from the breakfast (if consumed), lunch, food reward value task, and take home cooler minus energy expenditure during exercise (or comparable time period during rest).
Food intake from 8 am to 8 am; Energy expenditure from approximately 9 am to 9:05 am and 9:25 to 9:30 am, coinciding with study condition (rest or exercise)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lactate
Time Frame: 30 minutes, pre-post exercise (or rest)
Lactate values
30 minutes, pre-post exercise (or rest)
Acylated ghrelin
Time Frame: Immediately prior to lunch
Acylated ghrelin
Immediately prior to lunch
Self-reported binge eating
Time Frame: 24 and 48 hours after exercise/rest study visit

Participants will rate the extent the following questions, considering the time frame "since yesterday morning at 8 am" on a 1 to 5 scale from "not at all" to "extremely":

"While you were eating, to what extent did you feel a sense of loss of control?," "While you were eating, to what extent did you feel that you could not resist eating," "While you were eating, to what extent did you feel that you could not stop eating once you had started," and "While you were eating, to what extent did you feel driven or compelled to eat?" An answer of 4 or higher on any item will be categorized as binge eating present. Any reported binge eating on either day will be coded as binge eating being present

24 and 48 hours after exercise/rest study visit
Food reward value
Time Frame: Approximately 3:30 pm day of study visit
Number of trials according to task developed by Bodell and Keel 2015
Approximately 3:30 pm day of study visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 30, 2024

Primary Completion (Actual)

April 21, 2026

Study Completion (Actual)

April 21, 2026

Study Registration Dates

First Submitted

September 12, 2024

First Submitted That Met QC Criteria

September 17, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Actual)

April 30, 2026

Last Update Submitted That Met QC Criteria

April 24, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Data may be shared on a public repository, such as the Open Science Framework

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Binge-Eating Disorder

Clinical Trials on Rest

Subscribe